Tower Research Capital LLC (TRC) - VASCULAR BIOGENICS LTD ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$229
+6.0%
9370.0%0.00%
Q2 2023$2169370.0%0.00%
Q1 2023$09370.0%0.00%
Q4 2022$09370.0%0.00%
Q3 2022$0
-100.0%
937
-6.3%
0.00%
Q4 2021$2,000
-33.3%
1,000
-44.6%
0.00%
Q3 2018$3,000
+200.0%
1,805
+257.4%
0.00%
Q2 2018$1,000
-66.7%
505
-55.5%
0.00%
Q1 2018$3,000
-72.7%
1,134
-36.3%
0.00%
-100.0%
Q3 2017$11,000
+22.2%
1,781
-15.8%
0.00%0.0%
Q2 2017$9,000
+800.0%
2,114
+957.0%
0.00%
Q4 2016$1,0000.0%200
-17.4%
0.00%
Q1 2016$1,000
-66.7%
242
-48.9%
0.00%
Q2 2015$3,000
-94.6%
474
-95.6%
0.00%
-100.0%
Q1 2015$56,000
+600.0%
10,836
+665.8%
0.01%
+600.0%
Q4 2014$8,0001,4150.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 92,000$189,0000.26%
Ikarian Capital, LLC 790,838$1,622,0000.11%
PVG ASSET MANAGEMENT CORP 12,365$25,348,0000.08%
Phoenix Holdings Ltd. 1,020,000$2,091,0000.04%
DAFNA Capital Management LLC 55,000$113,0000.03%
ARK Investment Management 1,393,460$2,857,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$163,0000.01%
Total Clarity Wealth Management, Inc. 4,000$8,0000.00%
Virtu Financial LLC 15,298$31,0000.00%
Altshuler Shaham Ltd 209,000$431,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders